Testing cetirizine injection for acute hives
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have hives (or swelling under the skin) that started within the last 6 weeks.
- Your itching is at least mild and bothersome.
- You have visible hives or redness on your skin right now.
- You have not used certain allergy medicines (like antihistamines) in the last 2 hours, or steroid treatments in the last 4 hours, or epinephrine in the last 20 minutes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher dose of cetirizine (an allergy medicine) works better than the standard dose for treating sudden hives in adults. It may help people who have had new hives in the last day and are not taking certain other medicines.
This trial tests a new injection (CM512) for people with chronic spontaneous urticaria, also known as chronic hives. If you have had itchy hives for at least 6 weeks despite taking regular antihistamines, this study may help find a new treatment option.
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
This trial tests a new tablet (Alpha-0261) for chronic spontaneous urticaria (long-lasting hives without a clear cause). It aims to see if the drug is safe and tolerable. Part 1 includes people with chronic hives, and Part 2 looks at how food affects the drug in healthy adults.
This trial tests a new medicine, JYB1904, for people with chronic hives (itching and welts) that haven't been controlled by standard allergy pills. It aims to see if JYB1904 can reduce itching and hives better.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
Hear when a new Acute Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.